Karen Wheeler
Papers
1
Total Citations
15
H-Index
1
About
Dr. Karen Wheeler is a leading researcher in hereditary cancer syndromes, with a particular focus on gynecologic malignancies and renal cell carcinoma. Her work has significantly advanced the understanding of hereditary leiomyomatosis and renal cell cancer (HLRCC), a rare but aggressive cancer predisposition syndrome. Dr. Wheeler’s most cited study, “Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer” (2015, 15 citations), identified a previously unreported mutation in the fumarate hydratase (FH) gene, linking atypical uterine leiomyomas to HLRCC. This discovery has improved genetic screening protocols and risk assessment for affected families. Her contributions have been instrumental in bridging the gap between gynecologic pathology and oncology, highlighting the importance of recognizing uterine leiomyomas as potential markers for underlying cancer syndromes. Dr. Wheeler’s work continues to inform clinical guidelines and inspire further research into genotype-phenotype correlations in hereditary cancers, making her a pivotal figure in precision medicine for at-risk populations.
Research Focus
Key Achievements
Top Papers
- 1